...
首页> 外文期刊>Therapeutics and Clinical Risk Management >Low-density lipoprotein cholesterol of less than 70 mg/dL is associated with fewer cardiovascular events in acute coronary syndrome patients: a real-life cohort in Thailand
【24h】

Low-density lipoprotein cholesterol of less than 70 mg/dL is associated with fewer cardiovascular events in acute coronary syndrome patients: a real-life cohort in Thailand

机译:低于70 mg / dL的低密度脂蛋白胆固醇与急性冠脉综合征患者的心血管事件较少相关:泰国的一个现实生活队列

获取原文

摘要

Background: Elevated low-density lipoprotein cholesterol (LDL-C) is associated with an increased risk of cardiovascular disease or mortality; however, the LDL-C goal for therapy in acute coronary syndrome (ACS) patients is controversial and varies among guidelines. This study aimed to assess the effect of reaching an LDL-C goal of <70 mg/dL (<1.8 mmol/L) on first composite cardiovascular outcomes in routine clinical practice in Thailand. Methods: A retrospective cohort study was conducted using medical charts and the electronic hospital database of patients diagnosed with ACS and treated with statins at a tertiary care hospital in Thailand between 2009 and 2012. After admission, patients were followed from the date of LDL-C goal assessment until the first event of composite cardiovascular outcomes (nonfatal ACS, nonfatal stroke, or all-cause death). Cox proportional hazard models adjusted for potential confounders were used. Results: Of 405 patients, mean age was 65 years (60% males). Twenty-seven percent of the patients attained an LDL-C goal of <70 mg/dL, 38% had LDL-C between 70 and 99 mg/dL, and 35% had LDL-C ≥100 mg/dL. Forty-six patients experienced a composite cardiovascular outcome. Compared with patients with an LDL-C ≥100 mg/dL, patients achieving an LDL-C of <70 mg/dL were associated with a reduced composite cardiovascular outcome (adjusted hazard ratio [HR]=0.42; 95% confidence interval [CI]=0.18–0.95; P -value=0.037), but patients with an LDL-C between 70 and 99 mg/dL had a lower composite cardiovascular outcome, which was not statistically significant (adjusted HR=0.73; 95% CI=0.37–1.42; P -value=0.354). Conclusion: ACS patients who received statins and achieved an LDL-C of <70 mg/dL had significantly fewer composite cardiovascular outcomes, confirming “the lower the better” and the benefit of treating to LDL-C target in ACS patient management.
机译:背景:低密度脂蛋白胆固醇(LDL-C)升高与心血管疾病或死亡的风险增加有关;但是,LDL-C在急性冠状动脉综合征(ACS)患者中的治疗目标存在争议,并且在指南中有所不同。这项研究旨在评估在泰国的常规临床实践中,达到<70 mg / dL(<1.8 mmol / L)的LDL-C目标对首次复合心血管预后的影响。方法:采用回顾性队列研究方法,使用医学图表和电子病历数据库对2009年至2012年间泰国三级医院确诊为ACS并接受他汀类药物治疗的患者进行了回顾性研究。入院后从LDL-C日期开始追踪患者目标评估,直到首次发生复合心血管结果(非致命性ACS,非致命性中风或全因死亡)之前。使用针对潜在混杂因素调整的Cox比例风险模型。结果:405名患者中,平均年龄为65岁(男性为60%)。 LDL-C目标<70 mg / dL的患者有27%,LDL-C在70-99 mg / dL之间的患者为38%,LDL-C≥100mg / dL的患者为35%。四十六名患者经历了复合性心血管结果。与LDL-C≥100mg / dL的患者相比,LDL-C <70 mg / dL的患者与复合心血管结局的降低相关(校正风险比[HR] = 0.42; 95%置信区间[CI] ] = 0.18–0.95; P值= 0.037),但是LDL-C在70至99 mg / dL之间的患者的复合心血管结局较低,这在统计学上无统计学意义(校正后的HR = 0.73; 95%CI = 0.37)。 –1.42; P -value = 0.354)。结论:接受他汀类药物且LDL-C <70 mg / dL的ACS患者的复合心血管结局明显减少,这证实了ACS患者管理中“越低越好”以及针对LDL-C目标治疗的益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号